DLAT, as a Cuproptosis-Related Gene, Regulates Kidney Renal Clear Cell Carcinoma Progression

被引:1
|
作者
Zhang, Peizhi [1 ]
Qiu, Jiechuan [2 ]
Wang, Qingliang [2 ]
Xu, Yingkun [3 ]
Wang, Zicheng [2 ]
Peng, Fan [1 ]
Hao, Yuhu [1 ]
Wu, Guangzhen [4 ]
Xia, Qinghua [1 ,2 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Urol, Jinan 250021, Shandong, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan 250021, Shandong, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing 400042, Peoples R China
[4] Dalian Med Univ, Affiliated Hosp 1, Dept Urol, Dalian 116011, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
kidney renal clear cell carcinoma; dihydrolipidamide s-acetyltransferase; Cuproptosis; The Cancer Genome Atlas; Gene Expression Omnibus; PYRUVATE-DEHYDROGENASE COMPLEX; CANCER; AXIS;
D O I
10.23812/j.biol.regul.homeost.agents.20233703.128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cuproptosis is a novel discovered cell death mechanism in cancers. This study aimed to investigate the expression and prognostic value of DLAT (dihydrolipidamide s-acetyltransferase), one of the Cuproptosis-related genes, in kidney renal clear cell carcinoma (KIRC) using a comprehensive analysis integrating bioinformatics and experimental assays.Methods: High-throughput data and clinical information of KIRC patients were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. We used various R packages and bioinformatics analysis websites to analyze DLAT expression and function. Clinical tissue samples were used to verify DLAT expression in KIRC based on real-time quantitative reverse transcription (qRT-PCR) and immunohistochemistry. Subsequently, we validated DLAT differential expression in normal renal cells versus different KIRC cell lines using qRT-PCR. CCK-8 (cell counting kit-8) assay was used to assess the effect of DLAT overexpression on KIRC cells proliferation. Wound healing and Transwell assays were used to assess the effect of DLAT overexpression on KIRC cells invasion and migration.Results: DLAT mRNA expression in KIRC tumor tissue was lower than in normal kidney tissue. DLAT high expression suggested a good prognosis in KIRC. Gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that DLAT was involved in a variety of biological functions and pathways. Infiltration analysis indicated that DLAT might affect the prognosis of KIRC by affecting immune infiltration in the KIRC tumor microenvironment. qRT-PCR and immunohistochemistry further DLAT low expression in KIRC compared to normal kidney tissue. Besides, we found that DLAT overexpression could not only inhibit KIRC cells growth, but also effectively inhibit the migration and invasion of KIRC cell lines.Conclusions: This study explored the expression of DLAT in KIRC and the effect of DLAT on the proliferation, migration, and invasion of renal cancer cell lines, which has a positive role in guiding the diagnosis and treatment of KIRC.
引用
收藏
页码:1267 / 1283
页数:17
相关论文
共 50 条
  • [31] Confirmation of the predictive function of cuproptosis-related gene FDX1 in clear cell renal carcinoma using qRT-PCR and western blotting
    Cai, Congbo
    Zhou, Kena
    Jing, Jing
    Ren, Yu
    Weng, Guobin
    Cen, Dong
    Wang, Xue
    Huang, Shuaishuai
    AGING-US, 2023, 15 (13): : 6117 - 6134
  • [32] Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker
    Xu, Lidong
    Wu, Peipei
    Rong, Aimei
    Li, Kunkun
    Xiao, Xingguo
    Zhang, Yong
    Wu, Huili
    AGING-US, 2023, 15 (10): : 4269 - 4287
  • [33] Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
    Xiaoling Zhang
    Yuxin Zhou
    Jiahe Hu
    Xuefeng Yu
    Haitao Xu
    Zhichang Ba
    Haoxin Zhang
    Yanan Sun
    Rongfang Wang
    Xinlian Du
    Ruishu Mou
    Xuedong Li
    Jiuxin Zhu
    Rui Xie
    BMC Cancer, 23
  • [34] Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma
    Liu, Hengrui
    CANCER GENETICS, 2023, 274-275 : 21 - 25
  • [35] MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function
    Li, Zhipeng
    Zhou, Huaxin
    Zhai, Xiangyu
    Gao, Lin
    Yang, Mengfan
    An, Baokun
    Xia, Tong
    Du, Gang
    Li, Xiaoming
    Wang, Wei
    Jin, Bin
    CELL DEATH & DISEASE, 2023, 14 (11)
  • [36] A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma
    Gao, Wenjun
    He, Xiaoyan
    Huangfu, Qi
    Xie, Yanqi
    Chen, Keliang
    Sun, Chengfang
    Wei, Jingchao
    Wang, Bohan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (21-22)
  • [37] Up-regulation of Cuproptosis-related lncRNAS in Patients Receiving Immunotherapy for Metastatic Clear Cell Renal Cell Carcinoma Indicates Progressive Disease
    Katifelis, Hector
    Grammatikaki, Stamatiki
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Karamouzis, Michalis, V
    Stravodimos, Konstantinos
    Gazouli, Maria
    IN VIVO, 2025, 39 (01): : 146 - 151
  • [38] Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma
    Feng, Rui
    Li, Haolin
    Meng, Tong
    Fei, Mingtian
    Yang, Cheng
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [39] MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function
    Zhipeng Li
    Huaxin Zhou
    Xiangyu Zhai
    Lin Gao
    Mengfan Yang
    Baokun An
    Tong Xia
    Gang Du
    Xiaoming Li
    Wei Wang
    Bin Jin
    Cell Death & Disease, 14
  • [40] Cuproptosis-related gene DLAT is a biomarker of the prognosis and immune microenvironment of gastric cancer and affects the invasion and migration of cells
    Peng, Yanyu
    Shi, Ruimeng
    Yang, Siwen
    Zhu, Jiayi
    CANCER MEDICINE, 2024, 13 (14):